Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ocimene SCHEMBL157852 | 1.00 | TSHR (0.41) | TSHRALDH1A1TP53ALOX15 | |
| Ocimene SCHEMBL23589 | 1.00 | TSHR (0.41) | TSHRALDH1A1TP53ALOX15 | |
| Ocimene SCHEMBL15011309 | 1.00 | TSHR (0.41) | TSHRALDH1A1TP53ALOX15 | |
| Ocimene SCHEMBL15011308 | 0.83 | TSHR (0.48) | TSHRALDH1A1ALOX15 | |
| Ocimene SCHEMBL30518211 | 0.82 | TSHR (0.32) | TSHR | |
| Ocimene SCHEMBL29414419 | 0.82 | TSHR (0.32) | TSHR | |
| Ocimene SCHEMBL16011222 | 0.82 | BTN3A1 (0.46) | — | |
| Ocimene SCHEMBL8201861 | 0.82 | NR1I2 (0.37) | TSHR | |
| SCHEMBL8070910 | 0.81 | ALDH1A1 (0.32) | TSHRALDH1A1TP53 | |
| SCHEMBL25416695 | 0.80 | KMT2A (0.56) | TSHRALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 930 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3868206-B1 | A METHOD FOR THE HERBICIDAL TREATMENT OF DICOTYLEDONOUS WEEDS | RENDAPART (BE) | 2026-05-20 | — | — | EP | claimed |
| US-20260124219-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION | SRIN THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4709355-A1 | CANNABINOID-BASED FORMULATION | MRX Medical Limited (GB) | 2026-03-18 | — | — | EP | claimed |
| EP-4687452-A1 | ESSENTIAL OIL IMPREGNATED DEVICE AND METHODS OF USE THEREOF | Pertinent Eco-Solutions Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4680720-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EvodiaBio ApS (DK) | 2026-01-21 | — | — | EP | claimed |
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | Københavns Universitet (DK) | 2026-01-20 | — | — | US | claimed |
| US-12495802-B2 | Phagostimulant formulation for control of pest | R, Manoj Kumar (IN) | 2025-12-16 | — | — | US | claimed |
| US-12439914-B2 | Bactrocera oleae attractant composition and uses thereof | CEARITIS (FR) | 2025-10-14 | — | — | US | claimed |
| US-20250304517-A1 | STERIOISOMER-SPECIFIC CANNABIS FORMULATIONS AND ANALYSIS | SCIENTIFIC HOLDINGS, LLC (US) | 2025-10-02 | — | — | US | claimed |
| US-20250205127-A1 | COSMETIC AND NON-COSMETIC COMPOSITIONS AND METHODS OF USE | K&K BIOTECH (US) | 2025-06-26 | — | — | US | claimed |
| WO-2010148144-A1 | POLYMERIZATION OF ISOPRENE FROM RENEWABLE RESOURCES | DANISCO US INC. (US) | 2010-12-23 | — | — | WO | claimed |
| US-20100048964-A1 | COMPOSITIONS AND METHODS FOR PRODUCING ISOPRENE FREE OF C5 HYDROCARBONS UNDER DECOUPLING CONDITIONS AND/OR SAFE OPERATING RANGES | DANISCO US INC. | 2010-02-25 | — | — | US | claimed |
| WO-2010003007-A2 | COMPOSITIONS AND METHODS FOR PRODUCING ISOPRENE FREE OF C5 HYDROCARBONS UNDER DECOUPLING CONDITIONS AND/OR SAFE OPERATING RANGES | DANISCO US INC. (US) | 2010-01-07 | — | — | WO | claimed |
| US-20070264363-A1 | Molluscicidal and Anti-Barnacle Compounds | COMPTON DEVEOLOPMENT LTD (GB) | 2007-11-15 | — | — | US | claimed |
| EP-1682107-A1 | ANTI-TUMOUR TERPENE COMPOUNDS | Compton Developments, Ltd. (GB) | 2006-07-26 | — | — | EP | claimed |
| EP-1681933-A2 | MOLLUSCICIDAL AND ANTI-BARNACLE COMPOUNDS | Compton Developments, Ltd. (GB) | 2006-07-26 | — | — | EP | claimed |
| WO-2005051083-A2 | MOLLUSCICIDAL AND ANTI-BARNACLE COMPOUNDS | COMPTON DEVELOPMENTS LTD (GB) | 2005-06-09 | — | — | WO | claimed |
| WO-2005049001-A1 | ANTI-TUMOUR TERPENE COMPOUNDS | COMPTON DEVELOPMENTS LTD (GB) | 2005-06-02 | — | — | WO | claimed |
| US-20040247669-A1 | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth | BENNES, INC. | 2004-12-09 | — | — | US | claimed |
| US-20040151771-A1 | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth | BENNES, INC. | 2004-08-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529077-B2 | Production of geranyl diphosphate-derived compounds | GGPS1, OGA, GBA3 | TSHR 4055/4885ALDH1A1 2747/4885TP53 3171/4885 |
| US-20070264363-A1 | Molluscicidal and Anti-Barnacle Compounds | ACHE, BROX, BAD | TSHR 4817/4885ALDH1A1 525/4885TP53 4825/4885 |
| US-20260124219-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION | DEGS1, CNR2, CNR1 | TSHR 4183/4885ALDH1A1 3407/4885TP53 3340/4885 |
| US-20250205127-A1 | COSMETIC AND NON-COSMETIC COMPOSITIONS AND METHODS OF USE | KEAP1, NFE2, NFE2L2 | TSHR 4234/4885ALDH1A1 422/4885TP53 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.